Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins
Kyle L. O’Donnell, Tylisha Gourdine, Paige Fletcher, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17

Showing 17 citing articles:

Exosome-Based Multivalent Vaccine: Achieving Potent Immunization, Broadened Reactivity, and Strong T-Cell Responses with Nanograms of Proteins
Mafalda Cacciottolo, Justin B Nice, Yujia Li, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 24
OVX033, a nucleocapsid-based vaccine candidate, provides broad-spectrum protection against SARS-CoV-2 variants in a hamster challenge model
Charlotte Primard, Élodie Monchâtre-Leroy, Judith del Campo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Single dose recombinant VSV based vaccine elicits robust and durable neutralizing antibody against Hantaan virus
Hui Zhang, He Liu, Jing Wei, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
The Key to Increase Immunogenicity of Next-Generation COVID-19 Vaccines Lies in the Inclusion of the SARS-CoV-2 Nucleocapsid Protein
Noe Juvenal Mendoza-Ramírez, Julio García‐Cordero, Gaurav Shrivastava, et al.
Journal of Immunology Research (2024) Vol. 2024, pp. 1-18
Open Access | Times Cited: 6
Designing of an innovative conserved multiepitope subunit vaccine targeting SARS-CoV-2 glycoprotein and nucleoprotein through immunoinformatic
Temitope Isaac Adelusi, Abdeen Tunde Ogunlana, Moyosoluwa Precious Oyewole, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Replication-incompetent VSV-based vaccine elicits protective responses against SARS-CoV-2 and influenza virus
Richard Adeleke, Julie Sahler, Annette Choi, et al.
Science Advances (2025) Vol. 11, Iss. 5
Closed Access
Overview of Nucleocapsid-Targeting Vaccines against COVID-19
Alexandra Rak, Irina Isakova-Sivak, Larisa Rudenko
Vaccines (2023) Vol. 11, Iss. 12, pp. 1810-1810
Open Access | Times Cited: 10
Next-Generation Vaccines against COVID-19 Variants: Beyond the Spike Protein
Srinivasa Reddy Bonam, Haitao Hu
Zoonoses (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 8
A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection
Stephen Boulton, Joanna Poutou, Rida Gill, et al.
Molecular Therapy — Methods & Clinical Development (2023) Vol. 31, pp. 101110-101110
Open Access | Times Cited: 7
Heterologous chimpanzee adenovirus vector immunizations for SARS-CoV-2 spike and nucleocapsid protect hamsters against COVID-19
Mohadeseh Hasanpourghadi, Mikhail Novikov, Robert Ambrose, et al.
Microbes and Infection (2022) Vol. 25, Iss. 4, pp. 105082-105082
Open Access | Times Cited: 12
Viral vector- and virus-like particle-based vaccines against infectious diseases: A minireview
Ruth Henríquez, Isabel Muñoz‐Barroso
Heliyon (2024) Vol. 10, Iss. 15, pp. e34927-e34927
Open Access | Times Cited: 2
Effectiveness of VSV vectored SARS-CoV-2 spike when administered through intranasal, intramuscular or a combination of both
Saina Beitari, Gerard Agbayani, Melissa Hewitt, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Comparison of a SARS-CoV-2 mRNA booster immunization containing additional antigens to a spike-based mRNA vaccine against Omicron BA.5 infection in hACE2 mice
Jacklyn R. Hurst, Maedeh Naghibosadat, Patrick Budowski, et al.
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0314061-e0314061
Open Access
Exosome based multivalent vaccine: achieving potent immunization, broadened reactivity, and strong T cell responses with nanograms of proteins
Mafalda Cacciottolo, Justin B Nice, Yujia Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
SARS-Cov2 seasonality and adaptation are driven by solar activity.
Octavio Gonzalez-Lugo
Research Square (Research Square) (2023)
Open Access
SARS-Cov2 seasonality and adaptation are driven by solar activity.
Octavio Gonzalez-Lugo
Research Square (Research Square) (2023)
Open Access
SARS-Cov2 seasonality and adaptation are driven by solar activity.
Octavio Gonzalez-Lugo
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top